It would appear that his next hit-piece is already written and is hoping to fill-in some blanks. Where are his editors with this - it's shocking because STAT is owned by the parent that owns the Boston Globe which is known to be a follower of ethical journalistic standards. Why is this guy allowed to continue this sort of crap? My 20-year-old journalism degree is clearly useless - we were taught to report and write the news as it exists without opinion.

Quote:

---

This was posted on inv. hub; allegedly a letter from feuerstein to Olive digging for dirt on CYDY:

“Olive—I’m a reporter with STAT, a digital media company that covers health, medicine and life sciences. I’m interested in speaking to you about Holly Kennedy and her decision to be treated with Leronlimab, despite any clinical evidence of efficacy in treating TNBC. Your posts suggest she’s been helped by Leronlimab, yet she was hospitalized soon after returning to Ireland. It seems like her condition has worsened, not improved. What evidence is there that Leronlimab has helped her? Do you know if Holly has pursued treatment with Trodelvy, for instance, which was recently approved in the US for advanced TNBC? Are you worried at all that you and Holly are being exploited by people promoting Leronlimab and CytoDyn for financial reasons? I’d like to speak with you if you have time. Thank you — Adam Feuerstein “

Read More: https://investorshangout.com/post/view?id=585...z6Udcjutnw

---